Second study shows that octreotide may prevent early rebleeding in cirrhosis.
D'Amico
G
G
Politi
F
F
D'Antoni
A
A
Giannuoli
G
G
Pasta
L
L
Vizziani
G
G
Traina
M
M
Morabito
A
A
Pagliaro
L
L
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D004311:Double-Blind Method; D004932:Esophageal and Gastric Varices / Q000188:drug therapy*; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006471:Gastrointestinal Hemorrhage / Q000517:prevention & control*; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications; D015282:Octreotide / Q000627:therapeutic use*; D012008:Recurrence; D015911:Sclerotherapy / Q000379:methods
D000319:Adrenergic beta-Antagonists; D005765:Gastrointestinal Agents; D015282:Octreotide